BioCatalyst

IRON — Disc Medicine, Inc. catalysts

3 verified catalyst event(s) for Disc Medicine, Inc. (ticker IRON). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-09-01 — Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndro · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-09 (month)
in 2mo
ESTIMATED
 READOUT
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplas
Phase 1/2 · Myelofibrosis; Anemia, Anemia
 IRON Disc Medicine, Inc. DISC-0974 ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
2026-09 (month)
in 2mo
ESTIMATED
 READOUT
Study of Bitopertin in Participants With EPP or XLP (APOLLO)
Phase 3 · Erythropoietic Protoporphyria (EPP), X-Linked Protoporphyria (XLP)
 IRON Disc Medicine, Inc. DISC-1459 ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
2026-10 (month)
in 3mo
ESTIMATED
 READOUT
Study of DISC-0974-201 in Participants With IBD and Anemia
Phase 2 · Inflammatory Bowel Disease (IBD), Anemia
 IRON Disc Medicine, Inc. DISC-0974 ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.